Royal Bank of Canada
HUMA icon

Royal Bank of Canada’s Humacyte HUMA Stock Holding History

Royal Bank of Canada’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Sell
18,808
-2,013
-10% -$1.86K ﹤0.01% 6509
2026
Q1 		$13K Buy
20,821
+16,221
+353% +$16.9K ﹤0.01% 6061
2025
Q4 		$4K Sell
4,600
-492,399
-99% -$697K ﹤0.01% 6769
2025
Q3 		$865K Buy
496,999
+400,373
+414% +$784K ﹤0.01% 4091
2025
Q2 		$201K Buy
96,626
+96,507
+81,098% +$185K ﹤0.01% 5142
2025
Q1 		$0 Sell
119
-2,133
-95% -$8.01K ﹤0.01% 7003
2024
Q4 		$11K Sell
2,252
-6,399
-74% -$31.7K ﹤0.01% 6316
2024
Q3 		$47K Sell
8,651
-43,072
-83% -$284K ﹤0.01% 5725
2024
Q2 		$249K Sell
51,723
-7,209
-12% -$37.5K ﹤0.01% 4571
2024
Q1 		$183K Buy
58,932
+37,485
+175% +$126K ﹤0.01% 4763
2023
Q4 		$61K Buy
21,447
+11,448
+114% +$29.4K ﹤0.01% 5899
2023
Q3 		$29K Buy
9,999
+5,514
+123% +$18.2K ﹤0.01% 6041
2023
Q2 		$13K Buy
4,485
+428
+11% +$1.54K ﹤0.01% 6380
2023
Q1 		$12K Sell
4,057
-4,759
-54% -$13.5K ﹤0.01% 6232
2022
Q4 		$18K Buy
8,816
+8,591
+3,818% +$26.1K ﹤0.01% 6343
2022
Q3 		$1K Buy
225
+126
+127% +$483 ﹤0.01% 7195
2022
Q2 		$0 Sell
99
-2,348
-96% -$13.1K ﹤0.01% 7514
2022
Q1 		$17K Buy
2,447
+2,393
+4,431% +$13.9K ﹤0.01% 6688
2021
Q4 		$0 Buy
+54
New +$534 ﹤0.01% 7763
2021
Q2 		– Sell
-715
Closed -$8K – 7562
2021
Q1 		$8K Buy
+715
New +$7.81K ﹤0.01% 6891

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Royal Bank of Canada's HUMA Position: Q2 2026 in Review

Royal Bank of Canada reduced its Humacyte (HUMA) stake by 9.7% in Q2 2026, selling an estimated $1.86K and leaving 18,808 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #6509.

Royal Bank of Canada first reported a position in HUMA in Q1 2021 and has held it in 20 quarters since. The position peaked at $865K in Q3 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Royal Bank of Canada held 18,808 shares of Humacyte worth $14K as of Q2 2026.
  • Royal Bank of Canada sold 2,013 Humacyte shares in Q2 2026, an estimated $1.86K.
  • Humacyte made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6509 holding.
  • Royal Bank of Canada first reported a position in Humacyte in Q1 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's Humacyte position peaked at $865K in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.